Pfizer and BioNTech announced on Tuesday that the companies will start a human trial to evaluate the efficacy, safety, and tolerability of a vaccine specifically modified to target the omicron variant ...
Major COVID-19 vaccine manufacturers have begun testing modified shots targeting the Omicron variant as breakthrough infections keep surging worldwide, though it’s still unclear whether an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback